The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Feb. 27, 2018
Applicant:

Riken, Saitama, JP;

Inventor:

Shin-ichiro Fujii, Yokohama, JP;

Assignee:

RIKEN, Saitama, JP;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C07K 14/82 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); A61K 39/0011 (2013.01); C07K 14/4748 (2013.01); C07K 14/82 (2013.01); A61K 2039/5152 (2013.01); A61K 2039/5156 (2013.01); C07K 2319/00 (2013.01); C07K 2319/50 (2013.01);
Abstract

A cell for immunotherapy of the present invention includes a nucleic acid encoding a Wilms tumor 1 gene product or a fragment of the Wilms tumor 1 gene product, wherein the nucleic acid including (i) a region encoding a fragment of the Wilms tumor 1 gene product, the fragment being indicated by positions 194 to 493 of amino acid sequence of SEQ ID NO:1 or by positions corresponding to the positions 194 to 493 of amino acid sequence corresponding to SEQ ID NO:1 and (ii) only one AUG as a functional start codon, connected to a 5' terminal side of the region via 3m (m is 124-192) bases intervening between the AUG as the functional start codon and the 5′ terminal side of the region, and a nucleic acid encoding CD1d, wherein the cell has been loaded with a glycolipid recognized by antigen receptor of NKT cell.


Find Patent Forward Citations

Loading…